About
Technology
Issues
FAQ
Links
Official Page
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.